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Successful implementation of clinical guidelines for preventing complications of dyslipidemias has been an ongoing
challenge. The article by Vinker and colleagues in this journal investigates the results of implementing risk-based
guidelines for LDL (Low Density Lipoprotein) management in comparison to the prior approach of using the same
LDL cutoff for patients at all levels of risk. Results show LDL levels dropped across the primary care population using
the new risk-based approach, suggesting that clinical decision aids that link to individual patient characteristics,
rather than promoting a universal target for all, may provide a particularly strong stimulus for changing provider
and patient behavior. Results also challenge healthcare organizations, providers and patients to learn more about
the pathway from guidelines to clinical reminders and from reminders to lower LDL levels and better population
health.Background
A recent study in this journal provides fascinating glimpses
into the future of population-based guideline implementa-
tion, in addition to its implications for lipid management,
for use of computer reminders, and for understanding
healthcare provider behavior [1]. Undertaken by Vinker
and colleagues, the study documents lipid level outcomes
for the population of adults enrolled in a large managed
care organization (Clalit Health Services, with a population
of more than four million beneficiaries) after implementa-
tion of risk-based lipid management guidelines. Study data
follows the health system’s transition from a prior one size
fits all approach to the risk-based approach. Both the prior
approach and the new approach were supported by
computer-based clinical reminders.Risk-based guideline goals and implementation
results
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(based on Low Density Lipoprotein or LDL)—rather
than simply change in a process of care, such as the pro-
portion of patients tested for LDL. Risk groups are iden-
tified based on electronically available clinical factors
(e.g., heart disease, age, and smoking status). In the risk-
stratified approach, reminders targeted higher risk patients
for achieving more stringent goals. The new target for
high risk patients is an LDL-C level <100, while for
medium risk patients it is <130 and for low risk it is <160.
These targets are based on guidelines from the National
Cholesterol Education Program Adult Treatment panel III
(ATP III) [2]. In the earlier approach, reminders targeted
an LDL-C level of less than 100 across all risk groups.
Study outcome results retrospectively applied the new
guideline targets at both time periods, and showed signifi-
cant improvement in ATP III LDL goal attainment in the
later time period. Implementation of risk-stratified LDL
management linked to improved outcomes for each risk
group (high, medium and low). Results also showed in-
creases in physician prescribing of high potency statins
and a decrease in lower potency statins. As is often the
case in studies of real-world implementation of scientific
findings, however, the importance of study may rest asticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
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provides.
Looking forward
One question implied by the study is what role the
guidelines themselves had in shaping the study results.
Given that the ATP III guidelines came out in 2002 and
the risk-based computer reminder was implemented in
Clalit Health Services (henceforth Clalit) only in 2011,
study results are unlikely to be due to dissemination of
the new guidelines. The structure of the ATP III guide-
lines, however, provided clear support for a risk-based
approach, while the majority of existing clinical guide-
lines do not. While this study was not designed to test a
specific causal pathway to the LDL outcomes, the study
provides indirect evidence that risk-based guidelines
may be more motivating to clinicians, perhaps because
this type of guideline aligns better with clinical thinking
and knowledge. This conclusion is supported by prior
work using vignettes [3]. At the same time, advancing
information technology has enabled the widespread im-
plementation of nuanced, algorithm-based computer re-
minders that follow clinical guideline logic. Together,
risk-based guidelines and the availability of computer de-
cision support for implementing them can promote in-
corporation of information on differential risks and
benefits [4] into routine clinical decision-making. Doing
so may enable clinical reminders to achieve a closer
match to clinical thinking as well as to the goals of per-
sonalized medicine.
Computer reminders have become a standard of prac-
tice for assisting providers in achieving guideline adher-
ence. Prior to this study, an assumption might have been
that physicians would respond best to the simplest re-
minder, such as the prior reminder targeting an LDL
level of 100 for everyone. This study shows that a more
complex reminder can be motivating to clinicians. Yet
more complex reminders often require more computer
“clicks”, and can add to the workload in primary care. A
single extra click, for example, repeated over the number
of patients, physicians, and reminders in primary care
can add substantial cost. As reminders multiply, it will
be critical to assess when complexity is helpful and when
it is not, and to aim for the lowest workload approach
that achieves clinical goals. This study did not report on
human factors, such as time to complete, unclear in-
structions, or other usability characteristics. Is it time to
require those implementing reminders to report on user
acceptability and efficiency? My answer is yes; review of
data on the experiences of physicians and teams as they
use a new reminder should be an integral part of decid-
ing whether and how to implement it.
A prior meta-analysis showed that healthcare provider-
targeted interventions had a significant effect on patientmedication adherence. Adding interventions targeted at
improved integration of care or improved provider com-
munication skills with patients had enhanced effects [5].
Clalit results on improved LDL levels, by definition, re-
flect physician and primary care team effects on patient
adherence to either medications or lifestyle changes.
They may also reflect independent changes in patient
readiness to adopt LDL treatments, such as through
greater public awareness. Future work could address
additional questions about the paths from reminders to
provider behavior change to patient behavior change.
How did these providers transmit guideline recommen-
dations to patients? What did providers tell high versus
low risk patients with high LDLs? To what extent are
physicians informing patients about risk levels in help-
ing them make decisions about addressing their high
LDLs? And to what extent are patients responding to
their physician’s sense of urgency, versus to an under-
standing of their own health risks? The answers to these
and many other questions could contribute substantially
to future efforts to reduce population risks not only for
LDL but for other conditions. Clalit and other health
systems should promote evaluations of the pathways
from provider to patient behavior in order achieve the
high value, low waste care communities seek.
Despite this study’s demonstrated impacts on LDL
levels, study results inevitably pose questions about how
to enhance LDL impacts further, particularly among the
highest risk group. For example, the reminders in this
study targeted an LDL level of 100 for these high risk
patients, while other research and health systems have
targeted, for example, an LDL level of 70 for patients
with prior coronary artery disease, as discussed in ATP
III. Yet only 49 % of patients in the high risk group
achieved the target goal, leaving the remaining half of
the high risk population with a significant likelihood of
potentially preventable arteriosclerosis-related deaths.
60 % of the medium and low risk groups achieved an
identical target LDL of 100. The study thus raises ques-
tions about barriers to improvement in the high risk
group, and about what interventions might best help
this group. Further evaluation of the barriers to achiev-
ing LDL goals among the highest risk Clalit patients,
and further testing of methods for overcoming them, is
warranted.
Prior research on patients with chronic conditions
suggests mental health concerns as a key driver of poor
outcomes, especially among higher risk patients. A
meta-analysis of interventions directed at improving
hypertension care and outcomes pointed to stress, anx-
iety and depression as key barriers to adoption of a
healthier lifestyle [6]. We know that patients at high
risk of potentially preventable emergency department
use or hospitalization disproportionately have mental
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high risk high LDL patients who did not improve in re-
lationship to the Clalit intervention are likely to belong
to the overall high risk group of patients with multiple
chronic diseases and mental health impediments. Such
individuals are likely to be responsible for a disproportion-
ate share of overall healthcare costs, making them espe-
cially critical for efforts to create higher value healthcare.
Are different approaches needed to help these individuals
achieve their best health outcomes? Is the availability in
primary care of integrated mental health support or of
additional support for lifestyle change needed for these
individuals? Current information strongly suggests that
more intensive intervention is needed for a substantial
proportion of high risk patients.
As a related point, this study focused on physicians.
Currently, in many systems, physicians are solely respon-
sible for computer reminders. Yet primary care is moving
ever more toward a more inclusive, patient-centered view
that uses individual team members, including nurses and
clerks at the core, often in combination with linked social
workers, dietitians, mental health specialists and others
[8]. Nurse practitioners may be particularly effective [9]. It
would be helpful to know the extent to which additional
team members were important in producing the observed
improvements in this study. Furthermore, systematic ap-
proaches to involving non-physician healthcare profes-
sionals should be considered as a means for enhancing
lipid management.
Finally, this study points to the large effects computer
data views of the primary care population will have on
how we practice medicine. In previous eras, medical
personnel dealt with the patients in front of them. The
computer data view asks us to consider the whole popu-
lation, including those not seeking our care, or not will-
ing or able to follow our guidelines. Medicine has always
struggled with the tensions between the individual
practitioner-to-patient interaction and the view of medi-
cine as a major mediator of public health [10]. Health-
care professionals must discover how to resolve these
tensions as the ability to view the full population and its
outcomes becomes an increasing reality.
Conclusions
In summary, the Clalit study is an exemplar for system-
atic assessment of a quality improvement by a healthcare
delivery system. As such, it is part of the critical bridge
between rigorous scientific studies, guidelines that
synthesize them, and the implementation of the guide-
lines in clinical practice across a population. While each
individual real world study like this provides a window
into care, rather than a yes/no answer about intervention
efficacy, this and other similar studies of science as ap-
plied to routine care are critical to the ongoing careimprovement the public expects from its investments in
scientific discovery.
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